Journal Article
Research Support, Non-U.S. Gov't
Add like
Add dislike
Add to saved papers

Involvement of Nuclear Factor κ B, not Pregnane X Receptor, in Inflammation-Mediated Regulation of Hepatic Transporters.

Endotoxin-induced inflammation decreases the hepatic expression of several drug transporters, metabolizing enzymes, and nuclear transcription factors, including pregnane X receptor (PXR). As the nuclear factor κ B (NF- κ B) is a major mediator of inflammation, and reciprocal repression between NF- κ B and PXR signaling has been reported, the objective of this study was to examine whether NF- κ B directly regulates the expression of transporters or exerts its effect indirectly via PXR. PXR-deficient (-/-) or wild-type (+/+) male mice were dosed with the selective NF- κ B inhibitor PHA408 (40 mg/kg i.p.) or vehicle ( n = 5-8/group), followed by endotoxin (5 mg/kg) or saline 30 minutes later. Animals were sacrificed at 6 hours; samples were analyzed using quantitative reverse-transcription polymerase chain reaction and Western blots. Endotoxin induced tumor necrosis factor- α , interleukin (IL)-6, IL-1 β , and inducible nitric oxide synthase in PXR (+/+) and (-/-) mice. As compared with saline controls, endotoxin administration imposed 30%-70% significant decreases in the expression of Abcb1a, Abcb11, Abcc2, Abcc3, Abcg2, Slc10a1, Slco2b1, and Slco1a4 in PXR (+/+) and (-/-) mice to a similar extent. Preadministration of PHA408 attenuated endotoxin-mediated changes in both PXR (+/+) and (-/-) mice ( P < 0.05). Our findings demonstrate that endotoxin activates NF- κ B and imposes a downregulation of numerous ATP-binding cassette and solute carrier transporters through NF- κ B in liver and is independent of PXR. Moreover, inhibition of NF- κ B attenuates the impact of endotoxin on transporter expression. As NF- κ B activation is involved in many acute and chronic disease states, disease-induced changes in transporter function may be an important source of variability in drug response. This information may be useful in predicting potential drug-disease interactions.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app